Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

The number of traumatic amputations is rising worldwide—caused by road traffic accidents, accidents at work or during leisure ...

Chennai: Kauvery Hospital, Alwarpet, has performed a rare limb-saving endovascular procedure on a 93-year-old woman diagnosed ...

Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.

Treatment with an intramuscular hepatocyte growth factor reduced healing time and promoted full ulcer healing compared with placebo in patients with peripheral artery disease.

A man in the 40s presented with acute vertigo and occipital headache. He was diagnosed with right posterior inferior ...

The quality of healthcare in South Korea has improved, as evidenced by a decrease in hospital admission rates due to chronic diseases and the lowest 30-day mortality rate after stroke hospitalization ...

Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...

The FDA is adding a Boxed Warning label to delandistrogene moxeparvovec-rokl, a gene therapy for Duchenne muscular dystrophy, after reports of fatal liver injuries.

The sessions highlighted the latest advancements in the management of neurological, cardiac, coronary, aortic and peripheral ...

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...